LUBRANO, E.; SPADARO, A. Certolizumab: efficacy and safety profile of a novel pegylatedTNF-alpha blocking agent. Acta Biomedica Atenei Parmensis, Fidenza, Italy, v. 82, n. 1, p. 26–34, 2011. Disponível em: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1362.. Acesso em: 27 jul. 2024.